dailyai.report

A $400 million funding round values Chai Discovery at $3.8 billion. The startup uses artificial intelligence to accelerate drug discovery by predicting protein structures. This massive capital injection reflects high investor confidence in AI-driven biotech. Practitioners can expect faster lead optimization and reduced R&D timelines as these specialized models scale across the pharmaceutical sector.